Article Text

Download PDFPDF
Familial bicuspid aortic valve disease: should we look more closely at the valve?
  1. Romain Capoulade,
  2. Jean-Jacques Schott,
  3. Thierry Le Tourneau
  1. l’institut du thorax, INSERM, CNRS, CHU Nantes, Univ Nantes, Nantes, France
  1. Correspondence to Dr Romain Capoulade, l’institut du thorax, INSERM, CNRS, CHU Nantes, Univ Nantes, Nantes 44004, France; romain.capoulade{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Bicuspid aortic valve (BAV) is the most common congenital heart defect affecting 0.5%–2% of the adult population, with a male predominance of 3:1.1 BAV is usually characterised by the presence of two unequal-sized leaflets, the larger being the one with the raphe, which arises more frequently (approximately 70%–80%) between right and left coronary cusps.2

Several variants have been identified in sporadic BAV, such as NOTCH1 (9q34.3), FBN1 (15q21.1), NKX2-5 (5q34), MATR3 (5q31.2) and GATA5 (20q13.33), but none of them have provided consistent insight regarding causal mechanisms associated with this pathology. There is some evidence that BAV is the result of abnormal embryonic aortic cusps formation, but complete understanding of the mechanisms underlying this developmental disease remain elusive. In addition, non-valvular phenotypes are commonly documented in patients with BAV: aortic dilation or/and aneurysm are frequently associated abnormalities. This inter-relationship observed between BAV and other coexisting diseases can explain the gaps in understanding mechanisms associated with BAV formation and evolution over time.

Even if BAV is usually considered as a benign condition, an important clinical burden is associated with the disease. During adulthood, patients with BAV are more likely to develop life-threatening conditions such as infective endocarditis or severe aortic regurgitation and/or aortic stenosis, highlighting the important morbidity associated with BAV.2 This is also emphasised by the higher risk of undergoing valve surgery reported in patients with BAV as compared with patients with tricuspid aortic valve (TAV; almost 50% of patients undergoing surgery for isolated severe aortic stenosis present BAV).3 Nevertheless, even if such complications and rates of surgery could be associated with higher long-term risks for patients with BAV, no survival penalty has been reported.4 Recent approaches based on early identification of patients with BAV and familial screening, coupled with further close follow-up and ‘prophylactic’ surgery management could …

View Full Text


  • Contributors RC drafted the editorial. All authors reviewed the editorial and provided intelectual content.

  • Funding RC holds a ‘Connect Talent’ research chair from Region Pays de la Loire and Nantes Metropole (France).

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Linked Articles

  • Valvular heart disease
    Laura Galian-Gay Amelia Carro Hevia Gisela Teixido-Turà José Rodríguez Palomares Laura Gutiérrez-Moreno Giuliana Maldonado María Teresa Gonzàlez-Alujas Augusto Sao-Aviles Pastora Gallego Francisco Calvo-Iglesias Javier Bermejo Juan Robledo-Carmona Violeta Sánchez Daniel Saura Teresa Sevilla Sergio Burillo-Sanz Andrea Guala David Garcia-Dorado Arturo Evangelista On behalf of the BICUSPID investigators Chiara Granato Mireya Castro Elisa Blanco Candelas Pérez Del villar Ana González Mansilla Teresa Mombiela Raquel Prieto Maria Eugenia Vázquez M Angeles Espinosa Raquel Yotti Isabel Rodríguez-Bailón Adriana Rodríguez Chaverri Juan Francisco Delgado Jiménez Beatriz García-Aranda